CHRS vs. AUGO

Last updated Jun 3, 2026

CHRS (Coherus BioSciences, Inc.) and AUGO (Aura Minerals Inc. Common Shares) are both stocks. CHRS operates in Biotechnology (Healthcare), while AUGO operates in Gold (Basic Materials). At a 0.15 correlation, their price movements are largely independent.

Performance

CHRS vs. AUGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Coherus BioSciences, Inc. (CHRS) and Aura Minerals Inc. Common Shares (AUGO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CHRS achieves a 7.04% return, which is significantly lower than AUGO's 37.43% return.

CHRS

• 1D: -3.18%
• 1M: -15.56%
• YTD: 7.04%
• 6M: 31.03%
• 1Y: 98.43%
• 3Y*: -30.10%
• 5Y*: -34.94%
• 10Y*: -22.02%

AUGO

• 1D: -5.89%
• 1M: -16.32%
• YTD: 37.43%
• 6M: 74.09%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CHRS vs. AUGO - Yearly Performance Comparison

	2026 (YTD)	2025
CHRS Coherus BioSciences, Inc.	7.04%	57.78%
AUGO Aura Minerals Inc. Common Shares	37.43%	113.25%

Correlation

The correlation between CHRS and AUGO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 17, 2025	0.15

Fundamentals

Market Cap CHRS : $207.33M AUGO : $5.63B
EPS CHRS : $1.52 AUGO : $1.10
PE Ratio CHRS : 1.00 AUGO : 61.76
PS Ratio CHRS : 3.96 AUGO : 4.81
PB Ratio CHRS : 2.64 AUGO : 18.65
Total Revenue (TTM) CHRS : $46.88M AUGO : $1.14B
Gross Profit (TTM) CHRS : $23.41M AUGO : $644.49M
EBITDA (TTM) CHRS : -$162.15M AUGO : $394.37M

Return for Risk

CHRS vs. AUGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CHRS

CHRS Risk / Return Rank: 74
CHRS Sharpe Ratio Rank: 76
CHRS Sortino Ratio Rank: 74
CHRS Omega Ratio Rank: 70
CHRS Calmar Ratio Rank: 77
CHRS Martin Ratio Rank: 72

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CHRS vs. AUGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Coherus BioSciences, Inc. (CHRS) and Aura Minerals Inc. Common Shares (AUGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CHRS	AUGO	Difference
Sharpe ratio Return per unit of total volatility	1.22	—	—
Sortino ratio Return per unit of downside risk	1.95	—	—
Omega ratio Gain probability vs. loss probability	1.23	—	—
Calmar ratio Return relative to maximum drawdown	2.32	—	—
Martin ratio Return relative to average drawdown	4.28	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CHRS	AUGO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.22	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.41	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.29	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.22	3.65	-3.87

Drawdowns

CHRS vs. AUGO - Drawdown Comparison

The maximum CHRS drawdown since its inception was -98.21%, which is greater than AUGO's maximum drawdown of -37.01%. Use the drawdown chart below to compare losses from any high point for CHRS and AUGO.

Drawdown Indicators

	CHRS	AUGO	Difference
Max Drawdown Largest peak-to-trough decline	-98.21%	-37.01%	-61.20%
Max Drawdown (1Y) Largest decline over 1 year	-41.04%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-87.71%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-96.47%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-97.88%	—	—
Current Drawdown Current decline from peak	-95.94%	-37.01%	-58.93%
Average Drawdown Average peak-to-trough decline	-63.47%	-8.13%	-55.34%
Ulcer Index Depth and duration of drawdowns from previous peaks	22.21%	—	—

Volatility

Volatility by Period

	CHRS	AUGO	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.20%	—	—
Volatility (6M) Calculated over the trailing 6-month period	60.52%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	81.10%	66.20%	+14.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	84.63%	66.20%	+18.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	74.91%	66.20%	+8.71%

Dividends

CHRS vs. AUGO - Dividend Comparison

CHRS has not paid dividends to shareholders, while AUGO's dividend yield for the trailing twelve months is around 3.31%.

Position	TTM	2025
AUGO Aura Minerals Inc. Common Shares	3.31%	1.61%
CHRS Coherus BioSciences, Inc.	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both CHRS and AUGO in my portfolio?

CHRS and AUGO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.